- €172.61m
- €369.50m
- €566.32m
- 72
- 92
- 77
- 95
2019 December 31st | 2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | |
---|---|---|---|---|---|
Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
Source: | ARS | ARS | ARS | ARS | ARS |
Standards: | IFRS | IFRS | IFRS | IFRS | IFRS |
Status: | Final | Final | Final | Final | Final |
Revenue | |||||
Total Revenue | 434 | 470 | 588 | 606 | 566 |
Cost of Revenue | |||||
Gross Profit | 205 | 222 | 282 | 287 | 269 |
Selling / General / Administrative Expenses | |||||
Depreciation and Amortization | |||||
Unusual Expense / Income | |||||
Other Operating Expenses | |||||
Total Operating Expenses | 412 | 437 | 535 | 559 | 529 |
Operating Profit | 22 | 32.9 | 52.9 | 46.8 | 37.2 |
Total Net Non Operating Interest Income / Expense | |||||
Other Net Non Operating Costs | |||||
Net Income Before Taxes | 18.9 | 22.8 | 45.9 | 44.1 | 25.4 |
Provision for Income Taxes | |||||
Net Income After Taxes | 13.1 | 19.6 | 33.1 | 31.2 | 19.9 |
Minority Interest | |||||
Net Income Before Extraordinary Items | |||||
Net Income | 12.9 | 19.3 | 32.5 | 30.3 | 19.1 |
Income Available to Common Shareholders Excluding Extraordinary Items | |||||
Income Available to Common Shareholders Including Extraordinary Items | |||||
Diluted Net Income | 12.9 | 19.3 | 32.5 | 30.3 | 19.1 |
Diluted Weighted Average Shares | |||||
Basic EPS Including Extraordinary Items | |||||
Diluted EPS Including Extraordinary Items | |||||
Diluted EPS Excluding Extraordinary Items | |||||
Normalised Income Before Taxes | |||||
Normalised Income After Taxes | |||||
Normalised Income Available to Common Shareholders | |||||
Diluted Normalised EPS | 0.09 | 0.122 | 0.199 | 0.2 | 0.122 |
Dividends per Share |